
Cipher Gene was established in 2015 and focuses on genetic disease screening and diagnosis, birth defect prevention, translational medicine, and drug development services. The company leverages genetic technology to innovate in the diagnosis and treatment of genetic diseases, combining big data and artificial intelligence to provide precision medicine services to over 500 medical and research institutions globally. With a commitment to high-quality clinical services, Cipher Gene has become a leading enterprise in China's genetic disease diagnosis field, supported by a multidisciplinary research team and a robust intellectual property portfolio.

Cipher Gene was established in 2015 and focuses on genetic disease screening and diagnosis, birth defect prevention, translational medicine, and drug development services. The company leverages genetic technology to innovate in the diagnosis and treatment of genetic diseases, combining big data and artificial intelligence to provide precision medicine services to over 500 medical and research institutions globally. With a commitment to high-quality clinical services, Cipher Gene has become a leading enterprise in China's genetic disease diagnosis field, supported by a multidisciplinary research team and a robust intellectual property portfolio.